Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

The Big Lie of Bitcoin

By Dana Blankenhorn, InvestorPlace Contributor

Bitcoin growth has slowed because competition has increased. And, just because the cryptocurrency has value does not make it money.

Is United States Steel Corporation (X) Stock Worth the Risk?

By Dana Blankenhorn, InvestorPlace Contributor

U.S. Steel (X) is shutting plants to boost productivity, while the administration cuts import supplies with tariffs, allowing it to raise prices.

Fitbit Inc (FIT) Stock Nears All-Time Lows, Rolls the Dice

By Dana Blankenhorn, InvestorPlace Contributor

Fitbit has enough cash to get through one more Christmas season. The question is: Will FIT stock holders hang on that long?

Advanced Micro Devices, Inc. (AMD) Stock Rides the Bitcoin Boom

By Dana Blankenhorn, InvestorPlace Contributor

Advanced Micro Devices has a lower market cap than rivals, making AMD stock volatile. Bitcoin's boom is giving it gains, though, for now.

Why Rite Aid Corporation (RAD) Stock Can Survive These Stormy Waters

By Dana Blankenhorn, InvestorPlace Contributor

After the Walgreens deal, Rite Aid (RAD) is left with about 2,400 pharmacies, manageable debt and a growing pharmacy benefit manager, all of which can help RAD stock live on.

Load More